Table I.
Basic characteristics of patients with chemotherapy-sensitive (2 complete response and 7 partial response) and chemotherapy-resistant (12 stable disease and 0 progressive disease) cervical cancer.
| Categories | Chemotherapy-sensitive | Chemotherapy-resistant | P-value |
|---|---|---|---|
| Positive lymph node number FIGO stage, n (%) | 0.8±1.1 | 1.4±2.2 | 0.670 |
| IB2 | 4 (44.4) | 5 (41.7) | 1.000 |
| IIA2 | 5 (55.6) | 7 (58.3) | |
| Differentiation grades, n (%) | 0.155 | ||
| G1 | 4 (44.4) | 2 (16.7) | |
| G2 | 3 (33.3) | 9 (75.0) | |
| G3 | 2 (22.2) | 1 (8.3) | |
| Infiltration depth, n (%) | 0.397 | ||
| <50% | 4 (44.4) | 3 (25.0) | |
| ≥50% | 5 (55.6) | 9 (75.0) | |
| Maximum diameter of lesion pre-chemotherapy, mm | 6.0±1.0 | 4.9±1.7 | 0.088 |
| Percentage reduction in diameter of lesion post-chemotherapy, % | 51.2±22.5 | 5.3±22.4 | <0.001a |
a
P<0.05. FIGO, International Federation of Gynecology and Obstetrics.